Mallinckrodt pays $35 million fine for failing to report suspicious oxycodone orders -…

Intellipharmaceutics Announces FDA Advisory Committee Meeting for Rexista™ (oxycodone…

| Source: Intellipharmaceutics International Inc.

TORONTO, June 30, 2017 (GLOBE NEWSWIRE) — Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:IPCI) (“Intellipharmaceutics” or the “Company”), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today announced that a joint meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and (more…)

Biotech Hits 11-Year High On Potential To Dethrone Oxycodone – Investor’s Business Daily

Nektar Therapeutics (NKTR) stock soared more than 40% to an 11-year high Monday after unveiling strong data for a pain-relief pill that could be an alternative to the potentially addictive oxycodone.

In a phase three study of 600 patients, Nektar’s drug, known as NKTR-181, significantly improved chronic low back pain vs. a placebo in patients never treated with an opioid. The trial (more…)